Loan & DebtMay 28, 2026, 08:01 AM
Medicus Pharma Secures Up to $22M Structured Financing Facility
AI Summary
Medicus Pharma Ltd. announced it has entered into a definitive financing agreement with an institutional investor for an up to $22 million structured financing facility. This financing is expected to boost the company's pro forma cash position to approximately $30 million, providing a projected operating cash runway of over twenty-four months. The company will receive $12 million immediately, with an additional $10 million released upon achieving specified milestones, and intends to use the proceeds to advance clinical development programs, pursue strategic initiatives, and repay existing debt.
Key Highlights
- Medicus Pharma secured an up to $22 million structured financing facility.
- The financing is expected to increase the company's pro forma cash position to approximately $30 million.
- It provides a projected operating cash runway of more than twenty-four (24) months.
- Medicus will receive $12 million in immediate operating capital.
- An additional $10 million will be released upon achievement of certain milestones.
- The financing includes a $12.86 million secured promissory note at 8.75% interest and a $10 million secured promissory note at 5% interest.
- Net proceeds will support clinical development programs, strategic initiatives, and repay approximately $2.5 million in outstanding indebtedness.
- The notes are secured by substantially all Company assets and guaranteed by subsidiaries, with an 18-month maturity.
Price Impact
More from MDCX